The cardiovascular benefits of low-dosage acetylsalicylic acid

摘要

The increased risk of severe bleeding with use of acetylsalicylic acid (ASA) (odds ratio 2.2, 95% confidence interval [CI] 1.4–3.4) is outweighed by the 21% reduction (95% CI 0.72–0.88) in the odds of recurrent atherosclerotic events (coronary artery disease, ischemic stroke or transient ischemic attack) and 13% reduction (95% CI 0.76–0.98) in the odds of all-cause mortality.1